You must log in or register to comment.
Of course they say that.
“company says.”
Well, that’s enough legitimacy for me.
Well, it’s based on stage 3 study data. So it’s promising but hasn’t completed testing yet.
Phase 3 is the final stage of study and they are reporting on their results.
Yes, but still needs to be submitted for verification and approval. As per the article, they withdrew the precious application for a combined shot. It’s not clear if that’s due to more data, or just that this newer one is more promising.
This is still tied to specific strains. I was really hoping that we were getting closer to completing the generic one.
Still, yay progress.
